Genetic Predisposition and Inflammatory Inhibitors in COVID-19: Where Do We Stand?

Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) and the resulting coronavirus disease-19 (COVID-19) have led to a global pandemic associated with high fatality rates. COVID-19 primarily manifests in the respiratory system as an acute respiratory distress syndrome following viral entry t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sagris, Marios, Theofilis, Panagiotis, Antonopoulos, Alexios S., Oikonomou, Evangelos, Tsioufis, Kostas, Tousoulis, Dimitris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868779/
https://www.ncbi.nlm.nih.gov/pubmed/35203452
http://dx.doi.org/10.3390/biomedicines10020242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868779/
https://www.ncbi.nlm.nih.gov/pubmed/35203452
http://dx.doi.org/10.3390/biomedicines10020242

Ejemplares similares